📰 Andreaf Wainer News
Page 10 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
April 22, 2024
Sage Mountain Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,070 shares of the healthcare product maker’s stock after acquiring an additional 590 shares during the period. Sage Mountain […]
April 22, 2024
RWA Wealth Partners LLC lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 231.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 248,214 shares of the healthcare product maker’s stock after purchasing an additional 173,277 shares during the quarter. […]
April 22, 2024
Lee Danner & Bass Inc. cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,726 shares of the healthcare product maker’s stock after selling 340 shares during […]
April 21, 2024
Handelsbanken Fonder AB raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 13.7% in the 4th quarter, HoldingsChannel reports. The firm owned 2,042,235 shares of the healthcare product maker’s stock after purchasing an additional 246,836 shares during the quarter. Abbott Laboratories accounts for approximately 1.1% of Handelsbanken Fonder AB’s portfolio, making the stock […]
April 21, 2024
Vicus Capital lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 15.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,300 shares of the healthcare product maker’s stock after selling 767 shares during the period. Vicus Capital’s holdings in Abbott Laboratories were worth […]
April 21, 2024
OLD National Bancorp IN trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,004 shares of the healthcare product maker’s stock after selling 2,807 shares during the […]
April 21, 2024
Klingenstein Fields & Co. LP lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 129,255 shares of the healthcare product maker’s stock after selling 2,415 shares during the period. Klingenstein Fields & […]
April 21, 2024
Annapolis Financial Services LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 49.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 715 shares of the healthcare product maker’s stock after selling 687 shares during the quarter. Annapolis Financial […]
April 20, 2024
Geneva Partners LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 38.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,135 shares of the healthcare product maker’s stock after selling 2,552 shares during the period. […]
April 20, 2024
ZWJ Investment Counsel Inc. cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 47,231 shares of the healthcare product maker’s stock after selling 147 shares during the quarter. ZWJ Investment […]